Quarterly Result10 Aug 2026, 05:21 pm
Kimia Biosciences Declares Unaudited Q1 FY27 Results
AI Summary
Kimia Biosciences Ltd announced the approval of its unaudited financial results for the first quarter ended June 30, 2026. The Board of Directors met on August 10, 2026, to take on record the standalone financial results and the limited review report from the statutory auditors. The company operates within a single primary business segment, Pharmaceuticals.
Key Highlights
- Unaudited standalone financial results for Q1 FY27 approved.
- Board meeting held on August 10, 2026, to approve results.
- Limited Review Report from statutory auditors obtained.
- Company operates in a single segment: Pharmaceuticals.
Price Impact
More from KIMIABL